Vestcor Inc’s Novavax NVAX Stock Holding History

Vestcor Inc’s Portfolio NVAX Stock Details NVAX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-1,715	Closed	-$126K	–	1432
2022 Q1	$126K	Buy	1,715 +263	+18%	+$23.5K	﹤0.01%	1045
2021 Q4	$208K	Buy	1,452 +411	+39%	+$70.6K	0.01%	849
2021 Q3	$216K	Sell	1,041 -136	-12%	-$30K	0.01%	815
2021 Q2	$250K	Buy	+1,177	New	+$216K	0.01%	810

Other funds holding NVAX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Voloridge Investment Management Jupiter, Florida $25B AUM 28.08% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Vestcor Inc's NVAX Position: Q2 2022 in Review

Vestcor Inc sold out of Novavax (NVAX) in Q2 2022, closing a stake of 1,715 shares — an estimated $126K sold.

Vestcor Inc first reported a position in NVAX in Q2 2021 and held it in 4 quarters. The position peaked at $250K in Q2 2021. 325 funds tracked by Wall St. Rank hold NVAX as of Q2 2022.

Vestcor Inc reported no remaining Novavax position as of Q2 2022 after selling out during the quarter.
Vestcor Inc sold 1,715 Novavax shares in Q2 2022, an estimated $126K.
Vestcor Inc first reported a position in Novavax in Q2 2021 and held it in 4 quarters.
Vestcor Inc's Novavax position peaked at $250K in Q2 2021.
325 funds tracked by Wall St. Rank held Novavax as of Q2 2022.

Based on Vestcor Inc's 13F filing for Q2 2022, filed 15 Aug 2022.